Future clinical investigations are essential to validate the efficacy of these therapeutic targets in diabetic patient populations
Wegovy has demonstrated a weight loss of up to 15% of body weight in clinical trials, with a study published by The New England Journal of Medicine highlighting its effectiveness over a 68-week period
Wang M, Huang Y, Xin M, Li T, Wang X, Fang Y, Liang S, Cai T, Xu X, Dong L, Wang C, Xu Z, Song X, Li J, Zheng Y, Sun W, Li L (2023) The impact of microbially modified metabolites associated with obesity and bariatric surgery on antitumor immunity
A seven-day interval produces relatively stable exposure at steady state
And where does the name come from
Our team of experienced professionals will consider your medical history, current medications, and specific health conditions to ensure a safe and effective approach